Clinical trial · Interventional
Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls
NCT01173900CI-TRIAL-00005739completedPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aims of this study are: 1. To determine feasibility of a school-based human papillomavirus (HPV) vaccination programme in Tanzania. 2. To measure the uptake and acceptability of two different vaccination strategies in rural and urban schools. 3. To examine the characteristics of accepters/refusers of vaccination and to identify reasons for acceptance, refusal or non-completion. 4. To measure the cost of implementing a school-based HPV vaccination programme in Tanzania.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cervical Cancer | Malignant Cervical Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Gardasil® HPV vaccine | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- OTHER
- label
- Class-based delivery
- description
- All girls attending standard 6 in schools selected for class-based vaccine delivery
- interventionNames
- Biological: Gardasil® HPV vaccine
- type
- OTHER
- label
- Age-based delivery
- description
- All girls born in 1998 attending schools selected for age-based delivery
- interventionNames
- Biological: Gardasil® HPV vaccine
Primary outcomes (3)
- measure
- Vaccine coverage by delivery strategy
- timeFrame
- Month 12
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 9 Years
Show eligibility criteria text
Inclusion Criteria: * female pupil * attends selected school * born in 1998 if enrolled in school selected for age-based delivery * attending standard (class) 6 if enrolled in school selected for class-based delivery Exclusion Criteria: * has not previously received HPV vaccine * has not participated in previous HPV vaccine trials
References
Publications (2)
- DERIVEDQuentin W, Terris-Prestholt F, Changalucha J, Soteli S, Edmunds WJ, Hutubessy R, Ross DA, Kapiga S, Hayes R, Watson-Jones D. Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania. BMC Med. 2012 Nov 13;10:137. doi: 10.1186/1741-7015-10-137. PMID 23148516
- DERIVEDWatson-Jones D, Baisley K, Ponsiano R, Lemme F, Remes P, Ross D, Kapiga S, Mayaud P, de Sanjose S, Wight D, Changalucha J, Hayes R. Human papillomavirus vaccination in Tanzanian schoolgirls: cluster-randomized trial comparing 2 vaccine-delivery strategies. J Infect Dis. 2012 Sep 1;206(5):678-86. doi: 10.1093/infdis/jis407. Epub 2012 Jun 18. PMID 22711908